SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    In a new study led by Johns Hopkins Medicine, the experimental drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis), which is often incurable. Researchers say this study moves them closer to clinical trials for RK-33.

    LEARN MORE
    SEE ALL NEWS
    Recent Posts
    Colon Cancer Screening: What You Need to Know Detecting Early-Stage Cancers with a New Blood Test Measuring Epigenetic Instability Oral Bacterium May Promote Breast Cancer Development and Spread Extra Copies of Chromosome 1q May Drive Pancreatic Cancer How Bacteria May Promote Breast Cancer Growth of Spreading Pancreatic Cancer Fueled By “Under-Appreciated” Epigenetic Changes Updated Guidelines Standardize How Tumor Response Is Measured After Surgery Running the Distance: Patient Teams with Johns Hopkins Medicine Dermatologists to Treat, Understand Rare Hereditary Cancer Syndrome New Technology: MRI-guided Focused Ultrasound for Prostate Cancer
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top